申请人:Binggeli Alfred
公开号:US20060276508A1
公开(公告)日:2006-12-07
This invention is concerned with compounds of the formula
wherein R
1
to R
5
, R
5′
and A are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
这项发明涉及以下式中的化合物,其中R1至R5、R5'和A如描述和索赔中所定义,并且其药学上可接受的盐。该发明还涉及含有这种化合物的药物组合物,以及用于治疗和/或预防与调节SST受体亚型5相关的疾病的方法。